TC-2216
Chemical compound / From Wikipedia, the free encyclopedia
TC-2216 is a drug developed by Targacept which acts as a partial agonist at neural nicotinic acetylcholine receptors and was researched for the treatment of anxiety and depression.[1] It was unsuccessful as a therapeutic but is still used in pharmacological research as an alpha4beta2-selective antagonist.[2]
This article provides insufficient context for those unfamiliar with the subject. (March 2021) |
Quick Facts Identifiers, CAS Number ...
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H17N3 |
Molar mass | 203.289 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close